ARISTADA Trademark

Trademark Overview

On Tuesday, May 8, 2012, a trademark application was filed for ARISTADA with the United States Patent and Trademark Office. The USPTO has given the ARISTADA trademark a serial number of 85619287. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 22, 2022. This trademark is owned by Alkermes, Inc.. The ARISTADA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
aristada

General Information

Serial Number85619287
Word MarkARISTADA
Filing DateTuesday, May 8, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 22, 2022
Registration Number4893254
Registration DateTuesday, January 26, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 23, 2012

Trademark Statements

Goods and ServicesPharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
Translation of Words in MarkThe wording "ARISTADA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 15, 2012
Primary Code005
First Use Anywhere DateMonday, October 19, 2015
First Use In Commerce DateMonday, October 19, 2015

Trademark Owner History

Party NameALKERMES PHARMA IRELAND LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDublin 4
IE
Party NameALKERMES PHARMA IRELAND LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDUBLIN 4
IE
Party NameALKERMES PHARMA IRELAND LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressDUBLIN 4
IE
Party NameAlkermes, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 024511420

Trademark Events

Event DateEvent Description
Friday, May 11, 2012NEW APPLICATION ENTERED
Tuesday, May 15, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 22, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 29, 2012ASSIGNED TO EXAMINER
Wednesday, September 5, 2012EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 5, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, September 5, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 5, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, September 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 14, 2012ASSIGNED TO LIE
Monday, September 17, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 3, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 23, 2012PUBLISHED FOR OPPOSITION
Tuesday, October 23, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 13, 2013SOU TEAS EXTENSION RECEIVED
Thursday, June 13, 2013SOU EXTENSION 1 FILED
Thursday, June 13, 2013SOU EXTENSION 1 GRANTED
Saturday, June 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2013SOU TEAS EXTENSION RECEIVED
Monday, December 9, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 9, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 1, 2013SOU EXTENSION 2 FILED
Thursday, December 12, 2013SOU EXTENSION 2 GRANTED
Friday, December 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 18, 2014SOU TEAS EXTENSION RECEIVED
Friday, April 18, 2014SOU EXTENSION 3 FILED
Wednesday, April 23, 2014SOU EXTENSION 3 GRANTED
Thursday, April 24, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 17, 2014SOU TEAS EXTENSION RECEIVED
Monday, November 17, 2014SOU EXTENSION 4 FILED
Monday, November 24, 2014SOU EXTENSION 4 GRANTED
Tuesday, November 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 28, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 28, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 27, 2015SOU TEAS EXTENSION RECEIVED
Monday, April 27, 2015SOU EXTENSION 5 FILED
Tuesday, May 5, 2015SOU EXTENSION 5 GRANTED
Wednesday, May 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, November 3, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, November 3, 2015USE AMENDMENT FILED
Monday, December 14, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 17, 2015ASSIGNED TO EXAMINER
Tuesday, December 22, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 23, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, January 26, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 18, 2022TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 22, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 22, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 22, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, January 26, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 7, 2025TEAS SECTION 8 & 9 RECEIVED

Related Keywords

aristada diseases disorders system psychiatric neurodegenerative metabolic cardiovascular nervous central chemical